<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="636">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05152875</url>
  </required_header>
  <id_info>
    <org_study_id>2021/0060</org_study_id>
    <nct_id>NCT05152875</nct_id>
  </id_info>
  <brief_title>Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia</brief_title>
  <acronym>FunDyP</acronym>
  <official_title>Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia: Myth or Reality? Retrospective Study of Premature Infants Inferior to 29 Weeks of Gestation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Sud Francilien</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Sud Francilien</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine if fungal colonization is associated to severe&#xD;
      bronchopulmonary dysplasia in premature infants less than 29 weeks of gestation, and to&#xD;
      determine if an association exists between fungal colonization and complications of&#xD;
      prematurity and death.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fungal colonization is common in premature infants. Certain neonatal departments, routinely&#xD;
      screen for fungal colonization by weekly cultures, while other departments perform fungal&#xD;
      cultures solely in the presence of suggestive clinical or biological signs such as&#xD;
      hyperleucocytosis, maternal vaginal candidiasis, sepsis and characteristic skin lesions. This&#xD;
      neonatal colonization can progress to an invasive fungal infection leading to death and&#xD;
      comorbidities. A relationship between fungal colonization and severe bronchopulmonary&#xD;
      dysplasia is suspected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Severe bronchopulmonary dysplasia in premature infants inferior to 29 weeks of gestation</measure>
    <time_frame>at 36 weeks corrected age</time_frame>
    <description>Need of nCPAP, NIPPV, or nasal cannula â‰¥3 L/min with more than 30% of fraction inspired in Oxygen.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Necrotizing enterocolitis</measure>
    <time_frame>Day 0</time_frame>
    <description>Necrotizing enterocolitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraventricular haemorrhage grade 3 or 44</measure>
    <time_frame>Day 0</time_frame>
    <description>Intraventricular haemorrhage grade 3 or 44</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinopathy of prematurity</measure>
    <time_frame>Day 0</time_frame>
    <description>Retinopathy of prematurity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Invasive fungal infection</measure>
    <time_frame>Day 0</time_frame>
    <description>Invasive fungal infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>Day 0</time_frame>
    <description>Death</description>
  </secondary_outcome>
  <enrollment type="Anticipated">155</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <condition>Extreme Prematurity</condition>
  <condition>Fungal Infection</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>biological</intervention_name>
    <description>fungal colonization by weekly cultures</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort will be selected among all extremely premature infants admitted between January 2018&#xD;
        and December 2020 in the neonatal intensive care unit of Centre Hospitalier Sud Francilien&#xD;
        (Corbeil Essonnes 91, France)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Premature infants inferior to 29 weeks of gestation screened for fungal colonization,&#xD;
&#xD;
          -  Admitted in the neonatal department of Centre Hospitalier Sud Francilien,&#xD;
&#xD;
          -  Between January 1st 2018 and December 31st 2020,&#xD;
&#xD;
          -  Holders of parental authority informed of the study that are unopposed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Premature infants over 29 weeks of gestation, or term infants,&#xD;
&#xD;
          -  Premature infants less than 29 weeks of gestation not screened for fungal colonization&#xD;
             during their hospitalization,&#xD;
&#xD;
          -  Premature infants with significant congenital malformations or genetic abnormalities,&#xD;
&#xD;
          -  Premature infants inferior to 29 weeks of gestation deceased in delivery room.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>29 Weeks</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Taher LAMOUCHI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Sud Francilien</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed Taher LAMOUCHI, Md</last_name>
    <phone>0659720089</phone>
    <email>lamouchimohamed512@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline TOURTE</last_name>
    <phone>0161693150</phone>
    <email>caroline.tourte@chsf.fr</email>
  </overall_contact_backup>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 19, 2021</study_first_submitted>
  <study_first_submitted_qc>December 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2021</study_first_posted>
  <last_update_submitted>December 1, 2021</last_update_submitted>
  <last_update_submitted_qc>December 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Extremely premature infants</keyword>
  <keyword>Bronchopulmonary dysplasia</keyword>
  <keyword>fungal infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mycoses</mesh_term>
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
    <mesh_term>Hyperplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

